Advances in Breast Cancer Research

Breast cancer is the second most common cancer among American women. Breast cancer death rates have been falling over the past 30 years. But nearly 13% of women are still diagnosed in their lifetime. Men can get breast cancer too, although it’s rare. Researchers are studying the risk factors for different types of breast cancer.… Continue reading Advances in Breast Cancer Research

Blood Test Identifies More Treatable Cancers than Tissue Biopsy Alone

In one of the largest clinical studies to ever examine the impact of using a blood test to detect treatable mutations in non-small cell lung cancer (NSCLC), researchers from the Abramson Cancer Center of the University of Pennsylvania found that they could identify significantly more mutations through liquid biopsy instead of a solid tissue biopsy… Continue reading Blood Test Identifies More Treatable Cancers than Tissue Biopsy Alone

“Liquid Biopsy” Can Help Predict Outcomes in Metastatic Triple-Negative Breast Cancer

A clinically relevant “liquid biopsy” test can be used to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer (TNBC), according to research published in the February 20th 2018, print issue of the Journal of Clinical Oncology by a multi-institutional team of researchers with The Ohio State… Continue reading “Liquid Biopsy” Can Help Predict Outcomes in Metastatic Triple-Negative Breast Cancer